NEW YORK, Nov. 16, 2021 /PRNewswire/ -- Mind Medicine (MindMed) Inc. (NASDAQ: MNMD; NEO: MMED; DE: MMQ; the "Company"), a leading biotech company developing psychedelic-inspired therapies, is pleased ...

Drug overdoses can be life threatening, but for two women who accidentally took massive hits of LSD the experience was life changing -- and in a good way. A 46-year-old woman snorted a staggering 550 ...

After years of criminalization and marginalization, scientists have begun looking at LSD's medical benefits more closely, so much so that the Food and Drug Administration just issued a groundbreaking ...

(CNN) — A clinical trial’s encouraging results won US Food and Drug Administration breakthrough therapy status for an LSD formulation to treat generalized anxiety disorder, Mind Medicine Inc.

MindMed (NASDAQ:MNMD) (NEO: MMED) (DE: MMQ), a biotech company developing psychedelic-inspired therapies, announced its financial results late Monday for the third quarter ended Sept. 30, 2021.

The Beckley Foundation and its founder and long-time psychedelics researcher Amanda Feilding announced a new research program involving a pioneering study with King's College London and UCL on the ...

A single dose of LSD can cut anxiety in half within weeks, according to the results of a new study conducted by a biopharmaceutical company. MindMed, a clinical-stage company that develops novel ...

A 100 microgram dose of a pharmaceutical version of the hallucinogenic drug LSD could help stave off the symptoms of severe anxiety for weeks, a study suggests. Experts said the results are ...

A new study published in the journal Neuropsychopharmacology provided results from one of the first modern clinical investigations of its kind to compare the effects of psychedelic drugs lysergic acid ...

(CNN) — A clinical trial’s encouraging results won an LSD formulation approval from the US Food and Drug Administration as a breakthrough therapy for generalized anxiety disorder, Mind Medicine Inc.